Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics-Reference-Cited by-同舟云学术

Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics

Published:2020-05-07 Issue:11 Volume:15 Page:907-932
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Ghosh Arun K.¹²^ORCID,Brindisi Margherita¹³,Shahabi Dana¹,Chapman Mackenzie E.⁴,Mesecar Andrew D.¹⁴⁵

Affiliation:

1. Department of ChemistryPurdue University West Lafayette IN 47907 USA

2. Department of Medicinal Chemistry and Molecular PharmacolgyPurdue University West Lafayette IN 47907 USA

3. Department of Excellence of PharmacyUniversity of Naples Federico II 80131 Naples Italy

4. Department of BiochemistryPurdue University West Lafayette IN 47907 USA

5. Department of Biological SciencesPurdue University West Lafayette IN 47907 USA

Funder

National Institutes of Health

Purdue University

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202000223

Reference171 articles.

1. A new coronavirus associated with human respiratory disease in China

2. A pneumonia outbreak associated with a new coronavirus of probable bat origin

3. SARS-CoV-2 is an appropriate name for the new coronavirus

4. Coronavirus disease COVID pandemic. Accessed: March 20 2020: http://www.who.int/emergencies/diseases/novel-coronavirus-2019.

5. Coronavirus disease COVID pandemic 2020: situation summary. Accessed: March 20 2020: https://www.cdc.gov/coronaviru/2019-ncov/cases-updates/summary.html.

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Pyrano[2,3-c]pyrazole Derivatives as Novel Potential Human Coronavirus Inhibitors: Design, Synthesis, In Silico, In Vitro, and ADME Studies;Pharmaceuticals;2024-02-02

2. Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity;European Journal of Medicinal Chemistry;2024-02

3. Exploration of P1 and P4 modifications of nirmatrelvir: Design, synthesis, biological evaluation, and X-ray structural studies of SARS-CoV-2 Mpro inhibitors;European Journal of Medicinal Chemistry;2024-02

4. Lipid Metabolism Modulation during SARS-CoV-2 Infection: A Spotlight on Extracellular Vesicles and Therapeutic Prospects;International Journal of Molecular Sciences;2024-01-04

5. On the origins of SARS-CoV-2 main protease inhibitors;RSC Medicinal Chemistry;2024